In a recent study published in Nature Cancer, researchers explore treatment resistance and relapse in T-cell acute ...

Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM and the European ...

Human α–lactalbumin made lethal to tumor cells (HAMLET) is the first member in a new family of protein–lipid complexes that kills tumor cells with high selectivity. The protein component of ...

There may be fewer clinical trials for rare types of cancer than for more common types. It is hard to organise and run trials for rare cancers. Getting enough patients is critical to the success of a ...